Physician profile
Navid Ajabshir
NPI 1982053773
$14,499.66
in general payments reported to CMS, 2019-2025
15 companies · $1,514 in 2025
The $1,514 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.75 · 2022: $504 · 2024: $12K · 2025: $1,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,881 · Food and Beverage: $2,363 · Travel and Lodging: $1,228 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,880.71 |
| Food and Beverage | $2,363.10 |
| Travel and Lodging | $1,228.09 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $10,442.46 | 2024-2025 | Echelon Endopath, Echelon; Endopath, Harmonic |
| Medical Device Business Services, INC. | $1,072.76 | 2024-2025 | Echelon; Endopath |
| Ethicon INC. | $651.76 | 2024-2025 | Monarch Platform |
| Medtronic, INC. | $574.87 | 2022-2025 | Signia |
| Elucent Medical | $500.00 | 2024 | |
| On Target Laboratories, INC | $381.40 | 2025 | Cytalux |
| Davol INC. | $274.60 | 2024 | Progel Applicator Spray Tips |
| Galvanize Therapeutics, INC | $164.26 | 2025 | Aliya System |
| Intuitive Surgical, INC. | $132.47 | 2022-2024 | |
| Pinnacle Biologics, INC | $123.49 | 2024 | Photofrin |
| Astrazeneca Pharmaceuticals LP | $84.96 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $31.34 | 2024 | Dupixent |
| Abbott Laboratories | $23.75 | 2019 | |
| Atricure, INC. | $21.60 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Pulmonx Corporation | $19.94 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Ajabshir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.